Phase Genomics Receives $1.5MM NIH Grant to Develop Fast and Affordable Commercial Antimicrobial Resistance Tracking Kit SEATTLE, Washington, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Phase Genomics, Inc., the biotech leader providing proximity-ligation next-generation sequencing (NGS) solutions for metagenome assembly, today...

CDx Market Forecast Update: Congress Approves NIH Funding Wellesley, Mass., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Recently in March 2017, the FDA identified more than 1,000 Class II devices that it plans to exempt from 510(k) premarket notification...

Pressure on Investigator-Pharma Relationships Brings New Wave of Scrutiny, According to Cutting Edge Information RESEARCH TRIANGLE PARK, NC--(Marketwire - May 28, 2009) - As regulation clamps down on the commercial relationships between the industry and physicians, proponents of the scrutiny, such as Senator...